Related Experiment Video
Updated: Aug 14, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
The Potential of Complementary and Alternative Therapies in Improving Diarrhea-Predominant Irritable Bowel Syndrome:
Yuqing Deng1,2, Xinyi Ao1,2, Xin Liang1,2
1Department of Spleen and Stomach Diseases, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, No. 182, Chunhui Road, District of Longmatan, Luzhou, 646000, Sichuan, China.
Abstract:
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common disorder of gut-brain interaction. Current therapeutic approaches frequently fail to provide sustained symptom relief. In recent years, complementary and alternative therapies-particularly traditional Chinese medicine, acupuncture, and dietary interventions-have attracted increasing attention due to their low side-effect profiles and are gradually becoming important adjunct strategies in the management of IBS-D. This review systematically summarizes the research advances of the past decade across these three therapeutic categories for IBS-D with a focus on their clinical efficacy and underlying mechanisms. The findings suggest that traditional Chinese medicine, acupuncture, and dietary interventions can provide sustained relief from core symptoms of IBS-D, including diarrhea and abdominal pain. Their therapeutic effects are mediated through multiple mechanisms, including modulation of the gut microbiota and its metabolites, restoration of intestinal mucosal barrier integrity, attenuation of visceral hypersensitivity, and regulation of the gut-brain axis. These therapies exhibit multi-target and systemic effects with a low incidence of adverse events, highlighting their promising clinical potential. They offer feasible strategies for achieving long-term remission and facilitating personalized management of IBS-D.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome III: Medical and Nursing Management
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...